APO / LIPOPROTEINS

• Apoprotein A-I mimetic peptides and their potential anti-atherogenic mechanisms of action.
  (Getz GS, et al. Curr Opin Lipidol. 2009 Jun;20(3):171-5. Review.)
  View Abstract

BIOMARKERS

• Osteoprotegerin as an independent marker of subclinical atherosclerosis in osteoporotic postmenopausal women.
  (Shargorodsky M, et al. Atherosclerosis. 2009 Jun;204(2):608-11. Epub 2008 Oct 31.)
  View Abstract
• Plasma des-acyl ghrelin, but not plasma HMW adiponectin, is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensive patients.
  (Yano Y, et al. Atherosclerosis. 2009 Jun;204(2):590-4. Epub 2008 Nov 1.)
  View Abstract
• Inflammatory, hemostatic and other novel biomarkers for diabetic retinopathy: The Multi-Ethnic Study of Atherosclerosis (MESA).
  (Nguyen TT, et al. Diabetes Care. 2009 Jun 23. [Epub ahead of print])
  View Abstract
• Non-conventional markers of atherosclerosis before and after gastric banding surgery.
  (Hanusch-Enserer U, et al. Eur Heart J. 2009 Jun;30(12):1516-24. Epub 2009 Apr 20.)
  View Abstract
• Usefulness of ultrasonographic markers of carotid atherosclerosis (intima-media thickness, unstable carotid plaques and severe carotid stenosis) for predicting presence and extent of coronary artery disease.
  (Cicorella N, et al. J Cardiovasc Med (Hagerstown). 2009 Jun 10. [Epub ahead of print])
  View Abstract

DIABETES

• Association of endogenous sex hormones with diabetes and impaired fasting glucose in men: Multi-Ethnic Study of Atherosclerosis.
  (Colangelo LA, et al. Diabetes Care. 2009 Jun;32(6):1049-51. Epub 2009 Mar 16.)
  View Abstract
• Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis.
  (Wang CP, et al. Clin Endocrinol (Oxf). 2009 Jun;70(6):876-82. Epub 2008 Sep 5.)
  View Abstract
• The association between hemoglobin A1c and subclinical cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis.
  (McNeely MJ, et al. Diabetes Care. 2009 Jun 23. [Epub ahead of print])
  View Abstract

DRUG THERAPY

• Statins for all: The new premed?
  (Brookes ZL, et al. Br J Anaesth. 2009 Jul;103(1):99-107. Epub 2009 Jun 5. Review.)
  View Abstract
• Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
  (Lovren F, et al. Am J Physiol Endocrinol Metab. 2009 Jun;296(6):E1440-9. Epub 2009 Apr 7.)
  View Abstract
• Atherosclerosis in LDLR-knockout mice is inhibited, but not reversed, by the PPARgamma ligand pioglitazone.
  (Nakaya H, et al. Am J Pathol. 2009 Jun;174(6):2007-14. Epub 2009 May 12.)
  View Abstract
• Molecular mechanisms underlying the antiatherosclerotic and antidiabetic effects of probucol, succinobucol, and other probucol analogues.
  (Stocker R. Curr Opin Lipidol. 2009 Jun;20(3):227-35. Review.)
  View Abstract
• Medicare-eligible patients diagnosed with atherosclerosis: patterns in statin therapy and lipid monitoring.
  (Ohsfeldt RL, et al. Curr Med Res Opin. 2009 Jun;25(6):1403-11.)
  View Abstract
• Berberine promotes the development of atherosclerosis and foam cell formation by inducing scavenger receptor A expression in macrophage.
  (Li K, et al. Cell Res. 2009 Jun 23. [Epub ahead of print])
  View Abstract
• Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone).
  (Lonn EM, et al. J Am Coll Cardiol. 2009 Jun 2;53(22):2028-35.)
  View Abstract
• Pharmacoproteomics in cardiac hypertrophy and atherosclerosis.
  (Lazaro A, et al. Cardiovasc Hematol Disord Drug Targets. 2009 Jun;9(2):141-8.)
  View Abstract
• Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis.
  (Kerekes G, et al. Clin Rheumatol. 2009 Jun;28(6):705-10. Epub 2009 Mar 25.)
  View Abstract
• Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study.
  (Bots ML, et al. J Intern Med. 2009 Jun;265(6):698-707. Epub 2009 Mar 2.)
  View Abstract
• Effects of oral estrogen on aortic ROS-generating and -scavenging enzymes and atherosclerosis in apoE-deficient mice.
  (Chen Wing LY, et al. Exp Biol Med (Maywood). 2009 Jun 22. [Epub ahead of print])
  View Abstract
• Time trends in the use of anti-hypertensive medications: results from the Multi-Ethnic Study of Atherosclerosis.
  (Delaney JA, et al. Pharmacoepidemiol Drug Saf. 2009 Jun 23. [Epub ahead of print])
  View Abstract
• Novel therapeutic strategies targeting vascular redox in human atherosclerosis.
  (Antonopoulos AS, et al. Recent Pat Cardiovasc Drug Discov. 2009 Jun;4(2):76-87.)
  View Abstract Update on statin-mediated anti-inflammatory activities in atherosclerosis.
  (Montecucco F, et al. Semin Immunopathol. 2009 Jun;31(1):127-42. Epub 2009 May 5.)
  View Abstract
• Proteomic profiling during atherosclerosis progression using SELDI-TOF-MS: Effect of darbepoetin treatment.
  (Dursun E, et al. Acta Histochem. 2009 Jun 3. [Epub ahead of print])
  View Abstract

EPIDEMIOLOGY

• Relationship between aortic atherosclerosis and dental loss in an inner-city population.
  (Castillo R, et al. Angiology. 2009 Jun-Jul;60(3):346-50. Epub 2008 Sep 25.)
  View Abstract

GENETICS OF CARDIOVASCULAR DISEASE

• C-338A polymorphism of the endothelin-converting enzyme-1 gene and the susceptibility to carotid atherosclerosis.
  (Jin Z, et al. Microvasc Res. 2009 Jun;78(1):128-31. Epub 2009 Mar 14.)
  View Abstract
• SELP and SELPLG genetic variation is associated with cell surface measures of SELP and SELPLG: the Atherosclerosis Risk in Communities Carotid MRI Study.
  (Volcik KA, et al. Clin Chem. 2009 Jun;55(6):1076-82. Epub 2009 Apr 24.)
  View Abstract
• Hepatic lipase promoter C-480T polymorphism is associated with serum lipids levels, but not subclinical atherosclerosis: The Cardiovascular Risk in Young Finns Study.
  (Fan YM, et al. Clin Genet. 2009 Jun 22. [Epub ahead of print])
  View Abstract
• The HMG-CoA reductase gene and lipid and lipoprotein levels: The Multi-Ethnic Study of Atherosclerosis.
  (Chen YC, et al. Lipids. 2009 Aug;44(8):733-43. Epub 2009 Jun 25.)
  View Abstract
• Single nucleotide polymorphisms in monocyte chemoattractant protein-1 and its receptor act synergistically to increase the risk of carotid atherosclerosis.
  (Nyquist PA, et al. Cerebrovasc Dis. 2009;28(2):124-30. Epub 2009 Jun 5.)
  View Abstract

IMAGING

• Atherosclerosis of middle cerebral artery: Evaluation with high-resolution MR imaging at 3T.
  (1: Li ML, et al. Atherosclerosis. 2009 Jun;204(2):447-52. Epub 2008 Oct 25.)
  View Abstract
• Micro ATR-FTIR spectroscopic imaging of atherosclerosis: an investigation of the contribution of inducible nitric oxide synthase to lesion composition in ApoE-null mice.
  (Palombo F, et al. Analyst. 2009 Jun;134(6):1107-18. Epub 2009 Apr 2.)
  View Abstract
• Functional imaging of atherosclerosis to advance vascular biology.
  (Sakalihasan N, et al. Eur J Vasc Endovasc Surg. 2009 Jun;37(6):728-34. Epub 2009 Feb 15. Review.)
  View Abstract
• The mainstream hypothesis that LDL cholesterol drives atherosclerosis may have been falsified by non-invasive imaging of coronary artery plaque burden and progression.
  (Ware WR. Med Hypotheses. 2009 Jun 25. [Epub ahead of print])
  View Abstract
• Comparison of short-time Fourier transform and Eigenvector MUSIC methods using discrete wavelet transform for diagnosis of atherosclerosis.
  (Latifoglu F, et al. J Med Syst. 2009 Jun;33(3):189-97.)
  View Abstract
• Total cholesterol content of erythrocyte membranes and coronary atherosclerosis:
  An intravascular ultrasound pilot study.
  (Giannoglou GD, et al. Angiology. 2009 Jun 17. [Epub ahead of print])
  View Abstract
• Comparison of degree of stenosis and plaque volume for the assessment of carotid atherosclerosis using 2-D ultrasound.
  (de Labriolle A, et al. Ultrasound Med Biol. 2009 Jun 25. [Epub ahead of print])
  View Abstract
• Comparison of brachial and carotid artery ultrasound for assessing extent of subclinical atherosclerosis in HIV: a prospective cohort study.
  (Odueyungbo A, et al. AIDS Res Ther. 2009 Jun 11;6:11.)
  View Abstract
• Reproducibility and validity of lung density measures from cardiac CT Scans--
  The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study.
  (Hoffman EA, et al. Acad Radiol. 2009 Jun;16(6):689-99.)
  View Abstract
• Relationship between coronary artery and descending thoracic aortic calcification as detected by computed tomography: the Multi-Ethnic Study of Atherosclerosis.
  (Takasu J, et al. Atherosclerosis. 2009 Jun;204(2):440-6. Epub 2008 Oct 18.)
  View Abstract

IMMUNOLOGY

• Cytokine network and T cell immunity in atherosclerosis.
  (Ait-Oufella H, et al. Semin Immunopathol. 2009 Jun;31(1):23-33. Epub 2009 Apr 2.)
  View Abstract
• Vaccination against atherosclerosis? Induction of atheroprotective immunity.
  (Hansson GK, et al. Semin Immunopathol. 2009 Jun;31(1):95-101. Epub 2009 May 26.)
  View Abstract
• Innate and adaptive immunity in atherosclerosis.
  (Packard RR, et al. Semin Immunopathol. 2009 Jun;31(1):5-22. Epub 2009 May 16.)
  View Abstract
• Vaccination for atherosclerosis.
  (de Carvalho JF, et al. Clin Rev Allergy Immunol. 2009 Jun 26. [Epub ahead of print])
  View Abstract
• Connexins participate in the initiation and progression of atherosclerosis.
  (Morel S, et al. Semin Immunopathol. 2009 Jun;31(1):49-61. Epub 2009 Apr 30.)
  View Abstract
• Role for TNF in atherosclerosis? Lessons from autoimmune disease.
  (McKellar GE, et al. Nat Rev Cardiol. 2009 Jun;6(6):410-7.)
  View Abstract
• Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis.
  (Hsue PY, et al. AIDS. 2009 Jun 1;23(9):1059-67.)
  View Abstract
• Vaccination against TIE2 reduces atherosclerosis.
  (Hauer AD, et al. Atherosclerosis. 2009 Jun;204(2):365-71. Epub 2008 Oct 17.)
  View Abstract
• Lipodystrophy and anti-retroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjects.
  (Guaraldi G, et al. Atherosclerosis. 2009 Jun 18. [Epub ahead of print])
  View Abstract
• Obstructive sleep apnea, immuno-inflammation, and atherosclerosis.
  (Arnaud C, et al. Semin Immunopathol. 2009 Jun;31(1):113-25. Epub 2009 Apr 29.)
  View Abstract
• Translational mini-review series on immunology of vascular disease: accelerated atherosclerosis in vasculitis.
  (Cohen Tervaert JW. Clin Exp Immunol. 2009 Jun;156(3):377-85. Epub 2009 Mar 20. Review.)
  View Abstract

INFLAMMATION

• Extravascular inflammation does not increase atherosclerosis in apoE-deficient mice.
  (Ko KW, et al. Biochem Biophys Res Commun. 2009 Jun 19;384(1):93-9. Epub 2009 Apr 22.)
  View Abstract
• Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis.
  (Lehrke M, et al. Eur J Endocrinol. 2009 Aug;161(2):339-44. Epub 2009 Jun 4.)
  View Abstract
• Interleukin-18 predicts atherosclerosis progression in SIV-infected and uninfected rhesus monkeys (Macaca mulatta) on a high-fat/high-cholesterol diet.
  (Yearley JH, et al. Lab Invest. 2009 Jun;89(6):657-67. Epub 2009 Apr 20.)
  View Abstract

MODELING / INNOVATIVE TECHNIQUES

• Dimethylarginine dimethylaminohydrolase in rat penile tissue: reduced enzyme activity is responsible for erectile dysfunction in a rat model of atherosclerosis.
  (Park K, et al. Int J Impot Res. 2009 Jul-Aug;21(4):228-34. Epub 2009 Jun 18.)
  View Abstract
• A murine model of obesity with accelerated atherosclerosis.
  (King VL, et al. Obesity (Silver Spring). 2009 Jun 4. [Epub ahead of print])
  View Abstract
• Pitfalls in the assessment of murine atherosclerosis.
  (Catanozi S, et al. Braz J Med Biol Res. 2009 Jun;42(6):471-5.)
  View Abstract

METABOLIC SYNDROME

• Frequency and characteristics of metabolic syndrome in patients with symptomatic carotid atherosclerosis.
  (Maksimovic M, et al. Rev Med Chil. 2009 Mar;137(3):329-36. Epub 2009 Jun 15.)
  View Abstract

NUTRITION, DIET & METBOLISM

• Dietary pattern, the metabolic syndrome, and left ventricular mass and systolic function: The Multi-Ethnic Study of Atherosclerosis.
  (Liu L, et al. Am J Clin Nutr. 2009 Aug;90(2):362-8. Epub 2009 Jun 10.)
  View Abstract
• Aged garlic extract supplemented with B vitamins, folic acid and l-arginine retards the progression of subclinical atherosclerosis: A randomized clinical trial.
  (Budoff MJ, et al. Prev Med. 2009 Jun 30. [Epub ahead of print])
  View Abstract
• Correlation of erythrocyte fatty acid composition and dietary intakes with markers of atherosclerosis in patients with myocardial infarction.
  (Park Y, et al. Nutr Res. 2009 Jun;29(6):391-6.)
  View Abstract
• Adherence to the DASH diet is inversely associated with incidence of type 2 diabetes: The Insulin Resistance Atherosclerosis Study.
  (Liese AD, et al. Diabetes Care. 2009 Jun 1. [Epub ahead of print])
  View Abstract
• Resveratrol toxicity: Effects on risk factors for atherosclerosis and hepatic oxidative stress in standard and high-fat diets.
  (Rocha KK, et al. Food Chem Toxicol. 2009 Jun;47(6):1362-7. Epub 2009 Mar 17.)
  View Abstract

OBESITY

• Increased subcutaneous fat accumulation has a protective role against subclinical atherosclerosis in asymptomatic subjects undergoing general health screening.
  (Narumi H, et al. Int J Cardiol. 2009 Jun 26;135(2):150-5. Epub 2008 Jul 1.)
  View Abstract
• Obesity, inflammation, and atherosclerosis.
  (Rocha VZ, et al. Nat Rev Cardiol. 2009 Jun;6(6):399-409. Epub 2009 Apr 28.)
  View Abstract

PEDATRICS

• Subclinical atherosclerosis in diabetic children: results of a longitudinal study.
  (Pozza RD, et al. Pediatr Diabetes. 2009 Jun 10. [Epub ahead of print])
  View Abstract

RENAL DISEASE

• Prevalence and severity of atherosclerosis in renal artery in Northwest Indian population: an autopsy study.
  (Aggarwal A, et al. Surg Radiol Anat. 2009 Jun;31(5):349-56. Epub 2008 Dec 19.)
  View Abstract
• Kynurenine, quinolinic acid--the new factors linked to carotid atherosclerosis in patients with end-stage renal disease.
  (Pawlak K, et al. Atherosclerosis. 2009 Jun;204(2):561-6. Epub 2008 Oct 14.)
  View Abstract
• Differential associations of renal function with coronary and peripheral atherosclerosis.
  (Stamatelopoulos KS, et al. Int J Cardiol. 2009 Jun 26;135(2):162-4. Epub 2008 Jun 27.)
  View Abstract
• C-C chemokine receptor 2 expression by circulating monocytes influences atherosclerosis in patients on chronic hemodialysis.
  (Okumoto S, et al. Ther Apher Dial. 2009 Jun;13(3):205-12.)
  View Abstract
• Contribution of subcutaneous fat accumulation to insulin resistance and atherosclerosis in haemodialysis patients.
  (Gotoh H, et al. Nephrol Dial Transplant. 2009 Jun 17. [Epub ahead of print])
  View Abstract

RISK FACTORS

• Effects of timing and extent of smoking, type of cigarettes, and concomitant risk factors on the association between smoking and subclinical atherosclerosis.
  (Baldassarre D, et al. Stroke. 2009 Jun;40(6):1991-8. Epub 2009 Apr 9.)
  View Abstract
• Heart disease risk factors in midlife predict subclinical coronary atherosclerosis more than 25 years later in survivors without clinical heart disease: the Rancho Bernardo Study.
  (Barrett-Connor E, et al. J Am Geriatr Soc. 2009 Jun;57(6):1041-4.)
  View Abstract
• Is androgenetic alopecia a risk for atherosclerosis?
  (Dogramaci AC, et al. J Eur Acad Dermatol Venereol. 2009 Jun;23(6):673-7. Epub 2009 Feb 24.)
  View Abstract
• Long-term prognosis of patients with Kawasaki disease: at risk for future atherosclerosis?
  (Fukazawa R, et al. J Nippon Med Sch. 2009 Jun;76(3):124-33.)
  View Abstract
• CD40/CD154 system and pro-inflammatory cytokines in young healthy male smokers without additional risk factors for atherosclerosis.
  (Garlichs CD, et al. Inflamm Res. 2009 Jun;58(6):306-11.)
  View Abstract
• The association between fatal vascular events and risk factors for carotid atherosclerosis in patients on maintenance hemodialysis: plaque number of dialytic atherosclerosis study.
  (Maeda S, et al. Atherosclerosis. 2009 Jun;204(2):549-55. Epub 2008 Oct 8.)
  View Abstract
• Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance.
  (Messner B, et al. Arterioscler Thromb Vasc Biol. 2009 Jun 25. [Epub ahead of print])
  View Abstract
• Risk factors for coronary atherosclerosis in a general Japanese population: The Hisayama study.
  (Nakashima Y, et al. Pathol Res Pract. 2009 Jun 1. [Epub ahead of print])
  View Abstract
• Coffee intake, smoking, and pulmonary function in the Atherosclerosis Risk in Communities Study.
  (Nettleton JA, et al. Am J Epidemiol. 2009 Jun 15;169(12):1445-53. Epub 2009 Apr 16.)
  View Abstract
• Heritability and linkage analysis for carotid intima-media thickness: the family study of stroke risk and carotid atherosclerosis.
  (Sacco RL, et al. Stroke. 2009 Jul;40(7):2307-12. Epub 2009 Jun 4.)
  View Abstract
• More than skin deep: atherosclerosis as a systemic manifestation of psoriasis.
  (Alexandroff AB, et al. Br J Dermatol. 2009 Jul;161(1):1-7. Epub 2009 Jun 4.)
  View Abstract
• Atherosclerosis and disc degeneration/low-back pain--a systematic review.
  (Kauppila LI. Eur J Vasc Endovasc Surg. 2009 Jun;37(6):661-70. Epub 2009 Mar 27. Review.)
  View Abstract
• Management of atherothrombotic risk factors in high-risk Canadian outpatients.
  (Bell A, et al. Can J Cardiol. 2009 Jun;25(6):345-51.)
  View Abstract
• Police work and subclinical atherosclerosis.
  (Joseph PN, et al. J Occup Environ Med. 2009 Jun;51(6):700-7.)
  View Abstract

STROKE

• Elevated levels of soluble P-selectin in mice alter blood-brain barrier function, exacerbate stroke, and promote atherosclerosis.
  (Kisucka J, et al. Blood. 2009 Jun 4;113(23):6015-22. Epub 2009 Apr 6.)
  View Abstract
• Large vessel cerebral atherosclerosis is not in direct association with neuropathological lesions of Alzheimer's disease.
  (Luoto TM, et al. Eur Neurol. 2009;62(2):93-8. Epub 2009 Jun 12.)
  View Abstract
• Endothelial function in lacunar infarction: a comparison of lacunar infarction, cerebral atherosclerosis and control group.
  (Kim JS, et al. Cerebrovasc Dis. 2009;28(2):166-70. Epub 2009 Jun 25.)
  View Abstract
• Brachial artery hyperemic blood flow velocities are related to carotid atherosclerosis.
  (Järhult SJ, et al. Clin Physiol Funct Imaging. 2009 Jun 8. [Epub ahead of print])
  View Abstract
• Association between metabolic syndrome and carotid atherosclerosis in individuals without diabetes based on the oral glucose tolerance test.
  (Ishizaka N, et al. Atherosclerosis. 2009 Jun;204(2):619-23. Epub 2008 Oct 30.)
  View Abstract
• Association between impaired glucose tolerance and carotid atherosclerosis: a study in 64-year-old women and a meta-analysis.
  (Brohall G, et al. Nutr Metab Cardiovasc Dis. 2009 Jun;19(5):327-33. Epub 2008 Dec 20.)
  View Abstract
• Physical fitness and carotid atherosclerosis in men.
  (Lee CD, et al. Int J Sports Med. 2009 Jun 30. [Epub ahead of print])
  View Abstract
• Serum and dietary magnesium and risk of ischemic stroke: the Atherosclerosis Risk in Communities Study.
  (Ohira T, et al. Am J Epidemiol. 2009 Jun 15;169(12):1437-44. Epub 2009 Apr 16.)
  View Abstract

VASCULAR BIOLOGY

• Cholesterol oxidation products in the vascular remodeling due to atherosclerosis.
  (Poli G, et al. Mol Aspects Med. 2009 Jun;30(3):180-9. Epub 2009 Feb 25.)
  View Abstract
• Differentiation patterning of vascular smooth muscle cells (VSMC) in atherosclerosis.
  (Stintzing S, et al. Virchows Arch. 2009 Jun 26. [Epub ahead of print])
  View Abstract
• Segmental coronary endothelial dysfunction in patients with minimal atherosclerosis is associated with necrotic core plaques.
  (Lavi S, et al. Heart. 2009 Jun 3. [Epub ahead of print])
  View Abstract
• Left anterior descending artery length and coronary atherosclerosis in apical ballooning syndrome (Takotsubo/stress induced cardiomyopathy).
  (Hoyt J, et al. Int J Cardiol. 2009 Jun 30. [Epub ahead of print])
  View Abstract
• Race/ethnicity and telomere length in the Multi-Ethnic Study of Atherosclerosis.
  (Diez Roux AV, et al. Aging Cell. 2009 Jun;8(3):251-7. Epub 2009 Mar 17.)
  View Abstract
• Ankle-brachial index and extent of atherosclerosis in patients from the Middle East (the AGATHA-ME study): a cross-sectional multicenter study.
  (El-Menyar A, et al. Angiology. 2009 Jun-Jul;60(3):329-34. Epub 2008 Sep 26.)
  View Abstract
• Preclinical atherosclerosis covaries with individual differences in reactivity and functional connectivity of the amygdala.
  (Gianaros PJ, et al. Biol Psychiatry. 2009 Jun 1;65(11):943-50. Epub 2008 Nov 14.)
  View Abstract
• TGF-beta signaling in atherosclerosis and restenosis.
  (McCaffrey TA. Front Biosci (Schol Ed). 2009 Jun 1;1:236-45.)
  View Abstract
• Wall irregularity rather than intima-media thickness is associated with nearby atherosclerosis.
  (Graf IM, et al. Ultrasound Med Biol. 2009 Jun;35(6):955-61. Epub 2009 Feb 28.)
  View Abstract
• Evidence supporting a role for endoplasmic reticulum stress in the development of atherosclerosis in a hyperglycaemic mouse model.
  (Khan MI, et al. Antioxid Redox Signal. 2009 Jun 23. [Epub ahead of print])
  View Abstract

VASCULAR CALCIFICATION

• Osteoprotegerin, vascular calcification and atherosclerosis.
  (Van Campenhout A, et al. Atherosclerosis. 2009 Jun;204(2):321-9. Epub 2008 Oct 9.)
  View Abstract

The following articles were recommended by Eder Quintão, MD

• Acyl-coenzyme A:cholesterol acyltransferases.
  (Chang TY, et al. Am J Physiol Endocrinol Metab. 2009 Jul;297(1):E1-9. Epub 2009 Jan 13.)
  View Abstract
• Receptor-associated protein (RAP) has two high-affinity binding sites for the low-density lipoprotein receptor-related protein (LRP): consequences for the chaperone functions of RAP.
  (Jensen JK, et al. Biochem J. 2009 Jun 26;421(2):273-82.)
  View Abstract
• The cell cholesterol exporter ABCA1 as a protector from cardiovascular disease and diabetes.
  (Tang C, et al. Biochim Biophys Acta. 2009 Jul;1791(7):563-72. Epub 2009 Apr 1.)
  View Abstract
• Emerging new paradigms for ABCG transporters.
  (Tarr PT, et al. Biochim Biophys Acta. 2009 Jul;1791(7):584-93. Epub 2009 Jan 22.)
  View Abstract
• Intracellular sterol dynamics.
  ( Mesmin B, et al. Biochim Biophys Acta. 2009 Jul;1791(7):636-45. Epub 2009 Mar 12.)
  View Abstract
• Cholesterol transport in steroid biosynthesis: Role of protein-protein interactions and implications in disease states.
  (Rone MB, et al. Biochim Biophys Acta. 2009 Jul;1791(7):646-658. Epub 2009 Mar 12.)
  View Abstract
• Niemann-Pick C1 Like 1 (NPC1L1) an intestinal sterol transporter.
  (Davis HR Jr, et al. Biochim Biophys Acta. 2009 Jul;1791(7):679-83. Epub 2009 Jan 19.)
  View Abstract
• Overexpression of sterol carrier protein-2 differentially alters hepatic cholesterol accumulation in cholesterol-fed mice.
  (Atshaves BP, et al. J Lipid Res. 2009 Jul;50(7):1429-47. Epub 2009 Mar 16.)
  View Abstract
• ABCA1 plays no role in the centripetal movement of cholesterol from peripheral tissues to the liver and intestine in the mouse.
  ( Xie C, et al. J Lipid Res. 2009 Jul;50(7):1316-29. Epub 2009 Mar 12.)
  View Abstract